AUROBINDO PHARMA
Back to Income Statement
|
AUROBINDO PHARMA Last 5 Year Total Expenditure History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹25,141 Cr | ₹23,159 Cr | ₹21,137 Cr | ₹19,071 Cr | ₹19,441 Cr |
What is the latest Total Expenditure of AUROBINDO PHARMA ?
| Year | Total Expenditure |
|---|---|
| Mar2026 | ₹25,141 Cr |
| Mar2025 | ₹23,159 Cr |
| Mar2024 | ₹21,137 Cr |
| Mar2023 | ₹19,071 Cr |
| Mar2022 | ₹19,441 Cr |
How is Total Expenditure of AUROBINDO PHARMA Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2026 | ₹25,141 Cr | 8.56 | |
| Mar2025 | ₹23,159 Cr | 9.57 | |
| Mar2024 | ₹21,137 Cr | 10.83 | |
| Mar2023 | ₹19,071 Cr | -1.90 | |
| Mar2022 | ₹19,441 Cr | - | |
Compare Total Expenditure of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹93,962.8 Cr | 3.6% | -5.1% | 44.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.9% | -5% | 3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,611.0 Cr | 3.6% | -1.4% | 37.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,182.0 Cr | 1.7% | -6.7% | 28% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | 2.8% | -3.9% | -17.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,926.0 Cr | 5.4% | 8.7% | 1.6% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | 3.6% |
-5.1% |
44.5% |
| SENSEX | -0.3% |
-1.6% |
-12.3% |
You may also like the below Video Courses